Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Heterogeneity of Neointimal Healing Following Biodegradable-polymer Drug-Eluting Coronary Stent Implantation

NCT: NCT04465669 · COMPLETED

NCT IDNCT04465669
StatusCOMPLETED
Start Date2020-01-13
Completion2022-12-31
SponsorTomsk National Research Medical Center of the Russian Academy of Sciences (OTHER)
First posted
Last updated

Brief Summary

The objective of this study is a comparative evaluation of Orsiro stent and of Resolute Integrity stent in terms of the extent of neointima formation at 4 months after implantation using optical coherence tomography (OCT).

Frequently Asked Questions

What is Heterogeneity of Neointimal Healing Following Biodegradable-polymer Drug-Eluting Coronary Stent Implantation?

Heterogeneity of Neointimal Healing Following Biodegradable-polymer Drug-Eluting Coronary Stent Implantation is a clinical trial registered under NCT04465669. Current status: COMPLETED.

What is the status of NCT04465669?

The current status of NCT04465669 (Heterogeneity of Neointimal Healing Following Biodegradable-polymer Drug-Eluting Coronary Stent Implantation) is: COMPLETED.

When did Heterogeneity of Neointimal Healing Following Biodegradable-polymer Drug-Eluting Coronary Stent Implantation start?

Heterogeneity of Neointimal Healing Following Biodegradable-polymer Drug-Eluting Coronary Stent Implantation started on 2020-01-13.

Related Devices

K2312223D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1(type: Maestro2)Topcon Corporation K2335613D Optical Coherence Tomography (3D OCT-1(type: Maestro2))Topcon Corporation K2410813D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1 (type: Maestro2); IMAGEnet6 Ophthalmic Data SystemTopcon Corporation PMA P070015Coronary drug-eluting stentAbbott Vascular, Inc. PMA P110013Coronary drug-eluting stentMedtronic Vascular

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑